In silico clinical trial

Health Management Glossary

Research Methods

Definition. An in silico clinical trial uses patient-specific computer models, assembled into virtual cohorts, to test the safety or efficacy of a drug or medical device, either replacing part of a trial with human participants or complementing it.

Explanation

Pappalardo et al. (2019) describe in silico clinical trials as part of in silico medicine and note that a virtual set of patients could complement a conventional trial, reducing the number of enrolled patients, or advise clinical decisions. Digital twins and virtual patients are the building blocks, and regulators are increasingly accepting digital evidence (Moingeon et al., 2023).

Applications include virtual control arms built from existing data, as in a twin cohort of chronic graft-versus-host disease patients receiving standard care (Li et al., 2024), and AI-generated twins used as prognostic covariates, which in Alzheimer's disease trials would allow control arms 17% to 26% smaller at equal power (Wang et al., 2025). The evidence is only as good as the model, so credibility has to be established for the specific context of use through verification, validation and uncertainty quantification (Viceconti et al., 2021). See the Introduction 101 guide to digital twins in healthcare.

Related concepts

Randomized controlled trial (RCT) Target trial emulation Digital twin Verification, validation and uncertainty quantification (VVUQ)

Read on The Health Topics

References

Li, G., Chen, Y. B., & Peachey, J. (2024). Construction of a digital twin of chronic graft vs. host disease patients with standard of care. Bone Marrow Transplantation, 59(9), 1280-1285. https://doi.org/10.1038/s41409-024-02324-0

Moingeon, P., Chenel, M., Rousseau, C., Voisin, E., & Guedj, M. (2023). Virtual patients, digital twins and causal disease models: Paving the ground for in silico clinical trials. Drug Discovery Today, 28(7), Article 103605. https://doi.org/10.1016/j.drudis.2023.103605

Pappalardo, F., Russo, G., Tshinanu, F. M., & Viceconti, M. (2019). In silico clinical trials: Concepts and early adoptions. Briefings in Bioinformatics, 20(5), 1699-1708. https://doi.org/10.1093/bib/bby043

Viceconti, M., Pappalardo, F., Rodriguez, B., Horner, M., Bischoff, J., & Musuamba Tshinanu, F. (2021). In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products. Methods, 185, 120-127. https://doi.org/10.1016/j.ymeth.2020.01.011

Wang, D. L., Florian, H., Lynch, S. Y., Robieson, W., Zhuang, R., Kusiak, C., Ross, J. L., Walsh, J. R., & Graff, O. (2025). Using AI-generated digital twins to boost clinical trial efficiency in Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 11(4), Article e70181. https://doi.org/10.1002/trc2.70181

Cite this entry: Kurutkan, M. N. (2026). In silico clinical trial. In The Health Topics glossary. https://healthtopic.org/glossary/in-silico-clinical-trial/

Articles that discuss this concept

1 article on The Health Topics use this concept. The list updates as new articles are published.

Explore the knowledge graph →

← Back to the glossary